Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2017

01-04-2017 | Editorial

A Missed Screening Opportunity for Diabetes

Authors: Eva Tseng, MD, MPH, Nisa M. Maruthur, MD, MHS

Published in: Journal of General Internal Medicine | Issue 4/2017

Login to get access

Excerpt

Diabetes disproportionately affects members of racial and ethnic minority groups in the U.S.1 Compared to non-Hispanic whites (11.3%), the age-standardized prevalence of total diabetes is higher for Asian Americans (20.6%), Hispanic Americans (22.6%), and non-Hispanic blacks (21.8%).2 Given the burden of diabetes within these specific populations, the U.S. Preventive Services Task Force (USPSTF) revised its recommendations in 2014 to include screening for type 2 diabetes among certain racial and ethnic minority groups (African Americans, American Indians or Alaska Natives, Asians, Hispanics, and Native Hawaiians or other Pacific Islanders).1 Despite these recommendations, there is evidence that the prevalence of undiagnosed diabetes is higher among Asian Americans (50.9%) and Hispanic Americans (49.0%) compared to all other racial and ethnic minority groups.2 Although Asian Americans represent only 4.8% of the U.S. population, they are the fastest-growing racial group in the country, based on the 2010 Census.3
Literature
1.
go back to reference Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Dept. of Health and Human Services; 2015. Centers for Disease Control and Prevention. Diabetes Report Card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Dept. of Health and Human Services; 2015.
2.
go back to reference Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314(10):1021–1029.CrossRefPubMed Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314(10):1021–1029.CrossRefPubMed
3.
go back to reference Hoeffel EM, Rastogi S, Kim MO, Shahid H. The Asian Population: 2010. Washington, D.C.: U.S. Census Bureau; 2012. Hoeffel EM, Rastogi S, Kim MO, Shahid H. The Asian Population: 2010. Washington, D.C.: U.S. Census Bureau; 2012.
4.
go back to reference Tung EL, Baig AA, Huang ES, Laiteerapong N, Chua KP. Racial and Ethnic Disparities in Diabetes Screening between Asian Americans and Other Adults: BRFSS 2012–2014. J Gen Intern Med. 2016. doi:10.1007/s11606-016-3913-x.PubMed Tung EL, Baig AA, Huang ES, Laiteerapong N, Chua KP. Racial and Ethnic Disparities in Diabetes Screening between Asian Americans and Other Adults: BRFSS 2012–2014. J Gen Intern Med. 2016. doi:10.​1007/​s11606-016-3913-x.PubMed
5.
go back to reference Golden SH, Brown A, Cauley JA, et al. Health disparities in endocrine disorders: biological, clinical and nonclinical factors—an Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2012;97(9):E1579–E1639.CrossRefPubMedPubMedCentral Golden SH, Brown A, Cauley JA, et al. Health disparities in endocrine disorders: biological, clinical and nonclinical factors—an Endocrine Society Scientific Statement. J Clin Endocrinol Metab. 2012;97(9):E1579–E1639.CrossRefPubMedPubMedCentral
6.
go back to reference Professional Practice Committee of the American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Suppl. 1):S1–S2. Professional Practice Committee of the American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(Suppl. 1):S1–S2.
7.
go back to reference Siu AL, U.S. Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(11):861–868.CrossRefPubMed Siu AL, U.S. Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(11):861–868.CrossRefPubMed
9.
go back to reference Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150–158.CrossRefPubMed Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150–158.CrossRefPubMed
10.
go back to reference Holland AT, Palaniappan LP. Problems with the collection and interpretation of Asian-American health data: omission, aggregation and extrapolation. Ann Epidemiol. 2012;22(6):397–405.CrossRefPubMedPubMedCentral Holland AT, Palaniappan LP. Problems with the collection and interpretation of Asian-American health data: omission, aggregation and extrapolation. Ann Epidemiol. 2012;22(6):397–405.CrossRefPubMedPubMedCentral
Metadata
Title
A Missed Screening Opportunity for Diabetes
Authors
Eva Tseng, MD, MPH
Nisa M. Maruthur, MD, MHS
Publication date
01-04-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 4/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3970-1

Other articles of this Issue 4/2017

Journal of General Internal Medicine 4/2017 Go to the issue

Healing Arts: Materia Medica

A Gay Couple Meets Their Mormon Doctor

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.